NVOH Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged
Quote as of Oct 09, 2026 13:46 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 21.67 | Day Range | 21.67 – 21.67 |
| 52-Week Range | 19.00 – 34.36 | Volume | 65 |
| Avg Volume | 1.58K | AUM | $3.7M (Oct 10, 2026) |
| Expense Ratio | 0.19% | Yield (TTM) | 7.20% |
| NAV | 21.57 | Premium/Discount | +0.46% indicative |
| Inception | Jan 02, 2025 | Holdings | — |
| Issuer | ADR hedged | Exchange | AMEX |
| Category | Developed Markets | Index Tracked | Not stated in source data |
| CUSIP | 74016W841 | ISIN | US74016W8414 |
| Management | Not stated in source data | ||
About this ETF
This investment product primarily channels its resources, typically committing a minimum of 95% of its net assets, into American Depositary Receipts (ADRs) that represent the B Shares of Novo Nordisk A/S. It's crucial to understand that direct investment in the company's underlying shares is not part of this series' strategy. Additionally, the fund is structured as non-diversified, indicating a concentrated portfolio.
Description from the fund data provider · profile as of Oct 10, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | -9.81% | -19.03% | +5.47% | -20.59% | -32.31% | — | — | — | -37.22% |
| Total return | -9.81% | -19.03% | +8.90% | -16.90% | -27.90% | — | — | — | -34.72% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Oct 09, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.19% | Annual cost of a $10,000 investment | $19.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Oct 10, 2026 · portfolio reporting date from the data provider; holdings are not live positions. 2 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Novo Nordisk A/S (B Shares) | NVO | 93.71% | 89.53K | $3.4M |
| 2 | Cash (US$) | — | 6.29% | 0 | $229.5K |
Click a ticker to see every ETF that owns it.
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 7.20% | Paid (last 12 months) | $1.5598 |
| Frequency | Quarterly | SEC yield | Not provided by our data source; see the issuer page |
| Last ex-date | Sep 16, 2026 | Last payment | $0.0298 (Sep 23, 2026) |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Sep 16, 2026 | Sep 16, 2026 | Sep 23, 2026 | $0.0298 |
| Jun 16, 2026 | Jun 16, 2026 | Jun 23, 2026 | $0.7670 |
| Mar 16, 2026 | Mar 16, 2026 | Mar 23, 2026 | $0.2750 |
| Dec 16, 2025 | Dec 16, 2025 | Dec 24, 2025 | $0.4880 |
| Sep 16, 2025 | Sep 16, 2025 | Sep 23, 2025 | $0.1660 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 44.22% / — | Sharpe 1Y / 3Y | -0.498 / — |
| Max drawdown 1Y / 3Y | -40.91% / — | Sortino 1Y | -0.653 |
| Beta vs S&P 500 (3Y) | 0.833 | Correlation vs S&P 500 (1Y) | 0.228 |
| Downside deviation 1Y | 33.70% | Risk-free rate used | 4.05% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Oct 11, 2026. Formulas →
Liquidity
| Volume today | 65 | Average volume | 1.58K |
| AUM | $3.7M | Premium/Discount | +0.46% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV: an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | -$11.4K | -0.31% | $3.7M → $3.7M |
| 1 Month | -$291.3K | -6.84% | $4.3M → $3.7M |
| 1 Week | -$135.9K | -3.71% | $3.7M → $3.7M |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source; review them before investing.
Latest News for NVOH
No articles mention this fund directly in the last 7 days; showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.